{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:26:35Z","timestamp":1792135595748,"version":"4.4.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21701-3","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:29:52Z","timestamp":1761751792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Isolation, functional characterization and antibiofilm properties of a lytic Enterococcus phage RG1 against multidrug resistant E. faecium"],"prefix":"10.1038","volume":"15","author":[{"given":"Rakesh Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinnu","family":"Rain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradyot","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Kumar","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"21701_CR1","unstructured":"WHO, Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug resistant bacterial infections, including tuberculosis. World Health Organization No. WHO\/EMP\/IAU\/2017.12 (2017) 14\u201388."},{"key":"21701_CR2","doi-asserted-by":"publisher","unstructured":"Mogasale, V.V., Saldanha, P., Pai, V., Rekha, P.D. & Mogasale, V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Sci Rep. 11.1, 5116. https:\/\/doi.org\/10.1038\/s41598-021-84293-8 (2021).","DOI":"10.1038\/s41598-021-84293-8"},{"key":"21701_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","volume":"22","author":"LK McLellan","year":"2016","unstructured":"McLellan, L. K. & Hunstad, D. A. Urinary tract infection: pathogenesis and outlook. Trends Mol. Med. 22, 946\u2013957. https:\/\/doi.org\/10.1016\/j.molmed.2016.09.003 (2016).","journal-title":"Trends Mol. Med."},{"key":"21701_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.813145","volume":"12","author":"L Huang","year":"2021","unstructured":"Huang, L., Huang, C., Yan, Y., Sun, L. & Li, H. Urinary tract infection etiological profiles and antibiotic resistance patterns varied among different age categories: a retrospective study from a tertiary general hospital during a 12-year period. Front. Microbiol. 12, 813145. https:\/\/doi.org\/10.3389\/fmicb.2021.813145 (2021).","journal-title":"Front. Microbiol."},{"issue":"11","key":"21701_CR5","doi-asserted-by":"publisher","first-page":"5607","DOI":"10.1099\/ijsem.0.004332","volume":"70","author":"AC Parte","year":"2020","unstructured":"Parte, A. C., Sard\u00e0 Carbasse, J., Meier-Kolthoff, J. P., Reimer, L. C. & G\u00f6ker, M. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int. J. Syst. Evol. Microbiol. 70(11), 5607\u20135612. https:\/\/doi.org\/10.1099\/ijsem.0.004332 (2020).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"21701_CR6","unstructured":"Kristich, C. J., Rice, L. B., & Arias, C. A. Enterococcal infection\u2014treatment and antibiotic resistance. 1\u201362 (2014)."},{"issue":"52","key":"21701_CR7","doi-asserted-by":"publisher","first-page":"26925","DOI":"10.1073\/pnas.1916037116","volume":"116","author":"A Khan","year":"2019","unstructured":"Khan, A. et al. Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis. Proc Natl Acad Sci. 116(52), 26925\u201326932. https:\/\/doi.org\/10.1073\/pnas.1916037116 (2019).","journal-title":"Proc Natl Acad Sci."},{"issue":"6","key":"21701_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tim.2017.01.004","volume":"25","author":"RM van Harten","year":"2017","unstructured":"van Harten, R. M., Willems, R. J. L., Martin, N. I. & Hendrickx, A. P. A. Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?. Trends Microbiol. 25(6), 467\u2013479. https:\/\/doi.org\/10.1016\/j.tim.2017.01.004 (2017).","journal-title":"Trends Microbiol."},{"issue":"7","key":"21701_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 109(7), 309\u2013318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030 (2015).","journal-title":"Pathog Glob Health."},{"issue":"2","key":"21701_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/cid\/ciy064","volume":"67","author":"M Beganovic","year":"2018","unstructured":"Beganovic, M. et al. A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin. Infect Dis. 67(2), 303\u2013309. https:\/\/doi.org\/10.1093\/cid\/ciy064 (2018).","journal-title":"Clin. Infect Dis."},{"issue":"5","key":"21701_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00143-21","volume":"65","author":"GS Canfield","year":"2023","unstructured":"Canfield, G. S. et al. Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium. Antimicrob. Agents Chemother 65(5), 10\u20131128. https:\/\/doi.org\/10.1128\/aac.00143-21 (2023).","journal-title":"Antimicrob. Agents Chemother"},{"issue":"1","key":"21701_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/nyas.12468","volume":"1323","author":"HK Allen","year":"2014","unstructured":"Allen, H. K., Trachsel, J., Looft, T. & Casey, T. A. Finding alternatives to antibiotics. Ann. N. Y. Acad. Sci. 1323(1), 91\u2013100. https:\/\/doi.org\/10.1111\/nyas.12468 (2014).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"21701_CR13","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1073\/pnas.96.5.2192","volume":"96","author":"RW Hendrix","year":"1999","unstructured":"Hendrix, R. W., Smith, M. C., Burns, R. N., Ford, M. E. & Hatfull, G. F. Hatfull, Evolutionary relationships among diverse bacteriophages and prophages: All the world\u2019s a phage. Proc. Natl. Acad. Sci. USA 96, 2192\u20132197 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21701_CR14","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41596-020-0346-0","volume":"15","author":"T Luong","year":"2020","unstructured":"Luong, T., Salabarria, A. C., Edwards, R. A. & Roach, D. R. Standardized bacteriophage purification for personalized phage therapy. Nat. Protoc. 15, 2867\u20132890. https:\/\/doi.org\/10.1038\/s41596-020-0346-0 (2020).","journal-title":"Nat. Protoc."},{"key":"21701_CR15","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1128\/JVI.00385-15","volume":"89","author":"DP Pires","year":"2015","unstructured":"Pires, D. P., Vilas Boas, D., Sillankorva, S. & Azeredo, J. Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections. J. Virol. 89, 7449\u20137456. https:\/\/doi.org\/10.1128\/JVI.00385-15 (2015).","journal-title":"J. Virol."},{"key":"21701_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)","volume":"19","author":"P Jault","year":"2018","unstructured":"Jault, P. et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase, 1\/2 trial. Lancet Infect. Dis. 19, 35\u201345. https:\/\/doi.org\/10.1016\/S1473-3099(18) (2018).","journal-title":"Lancet Infect. Dis."},{"key":"21701_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fphar.2019.00513","volume":"10","author":"N Principi","year":"2019","unstructured":"Principi, N., Silvestri, E. & Esposito, S. Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections. Front. Pharmaco 10, 513 (2019).","journal-title":"Front. Pharmaco"},{"key":"21701_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/ph12010035","volume":"12","author":"P Hyman","year":"2019","unstructured":"Hyman, P. Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth. Pharmaceuticals. 12, 35 (2019).","journal-title":"Pharmaceuticals."},{"issue":"7","key":"21701_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 109(7), 309\u2013318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030 (2015).","journal-title":"Pathog Glob Health."},{"issue":"3","key":"21701_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/v5030806","volume":"5","author":"B Koskella","year":"2013","unstructured":"Koskella, B. & Meaden, S. Understanding bacteriophage specificity in natural microbial communities. Viruses 5(3), 806\u2013823. https:\/\/doi.org\/10.3390\/v5030806 (2013).","journal-title":"Viruses"},{"issue":"12","key":"21701_CR21","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/antibiotics13121120","volume":"13","author":"L Ribes-Mart\u00ednez","year":"2024","unstructured":"Ribes-Mart\u00ednez, L. et al. Bacteriophage Therapy as a Promising Alternative for Antibiotic-Resistant Enterococcus faecium: Advances and Challenges. Antibiotics (Basel). 13(12), 1120. https:\/\/doi.org\/10.3390\/antibiotics13121120 (2024).","journal-title":"Antibiotics (Basel)."},{"issue":"1","key":"21701_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5414\/cn107216","volume":"77","author":"R F\u00fcnfst\u00fcck","year":"2012","unstructured":"F\u00fcnfst\u00fcck, R. et al. Urinary tract infection in patients with diabetes mellitus. Clin. Nephrol. 77(1), 40\u201348. https:\/\/doi.org\/10.5414\/cn107216 (2012).","journal-title":"Clin. Nephrol."},{"key":"21701_CR23","doi-asserted-by":"publisher","unstructured":"Wang, M.C. et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection.\u00a0J. Microbiol. Immunol. Infect.\u00a046(1), 24\u201329. https:\/\/doi.org\/10.1016\/j.jmii.2011.12.024 (2013).","DOI":"10.1016\/j.jmii.2011.12.024"},{"key":"21701_CR24","doi-asserted-by":"publisher","first-page":"1416971","DOI":"10.3389\/fmicb.2024.1416971","volume":"15","author":"M Khazani Asforooshani","year":"2024","unstructured":"Khazani Asforooshani, M. et al. A novel Enterococcus faecium phage EF-M80: unveiling the effects of hydrogel-encapsulated phage on wound infection healing. Front. Microbiol. 15, 1416971. https:\/\/doi.org\/10.3389\/fmicb.2024.1416971 (2024).","journal-title":"Front. Microbiol."},{"key":"21701_CR25","doi-asserted-by":"publisher","unstructured":"Sarkis, G.J. & Hatfull, G.F. Mycobacteriophages, in Mycobacteria protocols (Humana Press), 145\u2013173 (1998). https:\/\/doi.org\/10.1385\/0-89603-471-2:145.","DOI":"10.1385\/0-89603-471-2:145"},{"key":"21701_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-60327-164-6_12","volume":"1","author":"HW Ackermann","year":"2009","unstructured":"Ackermann, H. W. Basic phage electron microscopy. Bacteriophages, Methods and protocols, Isolation, characterization, and interactions. 1, 113\u2013126. https:\/\/doi.org\/10.1007\/978-1-60327-164-6_12 (2009).","journal-title":"Bacteriophages, Methods and protocols, Isolation, characterization, and interactions."},{"issue":"3","key":"21701_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1085\/jgp.22.3.365","volume":"22","author":"EL Ellis","year":"1939","unstructured":"Ellis, E. L. & Delbruck, M. The growth of bacteriophage. J. Gen. Physiol. 22(3), 365\u2013384. https:\/\/doi.org\/10.1085\/jgp.22.3.365 (1939).","journal-title":"J. Gen. Physiol."},{"issue":"6","key":"21701_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1472-765X.2004.01525.x","volume":"38","author":"ML Capra","year":"2004","unstructured":"Capra, M. L., Quiberoni, A. & Reinheimer, J. A. Thermal and chemical resistance of lactobacillus casei and lactobacillus paracasei bacteriophages. Lett. Appl. Microbiol. 38(6), 499\u2013504. https:\/\/doi.org\/10.1111\/j.1472-765X.2004.01525.x (2004).","journal-title":"Lett. Appl. Microbiol."},{"issue":"2","key":"21701_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2672.2005.02767.x","volume":"100","author":"ML Capra","year":"2006","unstructured":"Capra, M. L., Quiberoni, A. & Reinheimer, J. Phages of lactobacillus casei\/paracasei: response to environmental factors and interaction with collection and commercial strains. J. Appl. Microbiol 100(2), 334\u2013342. https:\/\/doi.org\/10.1111\/j.1365-2672.2005.02767.x (2006).","journal-title":"J. Appl. Microbiol"},{"key":"21701_CR30","doi-asserted-by":"publisher","unstructured":"Nishiguchi, M.K. et al. DNA isolation procedures. In Techniques in molecular systematics and evolution (Basel: Birkh\u00e4user), 249\u2013287 (2002). https:\/\/doi.org\/10.1007\/978-3-0348-8125-8_12.","DOI":"10.1007\/978-3-0348-8125-8_12"},{"key":"21701_CR31","unstructured":"Fleming, E.A. The Isolation and Characterization of Novel Mycobacteriophages, Chancellor\u2019s Honors Program Projects, (2004). https:\/\/trace.tennessee.edu\/utk_chanhonoproj\/736."},{"key":"21701_CR32","doi-asserted-by":"crossref","unstructured":"Li., D. et al. MEGAHIT v1. 0: a fast and scalable metagenome assembler driven by advanced methodologies and community practices. Methods, 102, pp.3\u201311 (2016).","DOI":"10.1016\/j.ymeth.2016.02.020"},{"issue":"5","key":"21701_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41587-020-00774-7","volume":"39","author":"S Nayfach","year":"2021","unstructured":"Nayfach, S. et al. CheckV assesses the quality and completeness of metagenome-assembled viral genomes. Nat. Biotechnol. 39(5), 578\u2013585. https:\/\/doi.org\/10.1038\/s41587-020-00774-7 (2021).","journal-title":"Nat. Biotechnol."},{"key":"21701_CR34","doi-asserted-by":"publisher","unstructured":"Bouras, G. et al. Pharokka: a fast scalable bacteriophage annotation tool. Bioinformatics. 1;39, 776 (2023). https:\/\/doi.org\/10.1093\/bioinformatics\/btac776.","DOI":"10.1093\/bioinformatics\/btac776"},{"issue":"11","key":"21701_CR35","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nbt.3988","volume":"35","author":"M Steinegger","year":"2017","unstructured":"Steinegger, M. & S\u00f6ding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat Biotechnol. 35(11), 1026\u20131028. https:\/\/doi.org\/10.1038\/nbt.3988 (2017) (Epub 2017 Oct 16).","journal-title":"Nat Biotechnol."},{"issue":"7","key":"21701_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/bioinformatics\/btr039","volume":"27","author":"MJ Sullivan","year":"2011","unstructured":"Sullivan, M. J., Petty, N. K. & Beatson, S. A. Easyfig: a genome comparison visualize. Bioinformatics 27(7), 1009\u20131010. https:\/\/doi.org\/10.1093\/bioinformatics\/btr039 (2011).","journal-title":"Bioinformatics"},{"key":"21701_CR37","doi-asserted-by":"publisher","unstructured":"Moraru, C., Varsani, A. & Kropinski, A.M. VIRIDIC\u2014A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses. Viruses 12(11), 1268. https:\/\/doi.org\/10.3390\/v12111268  (2020).","DOI":"10.3390\/v12111268"},{"issue":"7","key":"21701_CR38","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol. Evol. 38(7), 3022\u20133027 (2021).","journal-title":"Mol Biol. Evol."},{"key":"21701_CR39","doi-asserted-by":"crossref","unstructured":"Harwood, V. J. et al. Molecular confirmation of Enterococcus faecalis and E. faecium from clinical, faecal and environmental sources. Lett. Appl. Microbiol. 38(6), 476\u2013482 (2004).","DOI":"10.1111\/j.1472-765X.2004.01518.x"},{"issue":"3","key":"21701_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/jgid.jgid_91_16","volume":"9","author":"AK Singh","year":"2017","unstructured":"Singh, A. K. et al. Standardization and Classification of In vitro Biofilm Formation by Clinical Isolates of Staphylococcus aureus. J Glob Infect Dis. 9(3), 93\u2013101. https:\/\/doi.org\/10.4103\/jgid.jgid_91_16 (2017).","journal-title":"J Glob Infect Dis."},{"key":"21701_CR41","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1128\/AAC.00349-11","volume":"55","author":"CL Lu","year":"2011","unstructured":"Lu, C. L. et al. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother. 55, 4295\u20134301 (2011).","journal-title":"Antimicrob Agents Chemother."},{"key":"21701_CR42","doi-asserted-by":"publisher","unstructured":"Maurya, G.K., Kota, S. & Misra, H.S. Characterisation of ParB encoded on multipartite genome in Deinococcus radiodurans and their roles in radioresistance. Microbiol. Res. 223\u2013225. https:\/\/doi.org\/10.1016\/j.micres.2019.03.005 (2019).","DOI":"10.1016\/j.micres.2019.03.005"},{"key":"21701_CR43","doi-asserted-by":"publisher","unstructured":"Goodarzi, F. et al. Anti-biofilm Activity of a Lytic Phage Against Vancomycin-Resistant Enterococcus faecalis. Iran. J. Pathol. 17.3, 285\u2013293. https:\/\/doi.org\/10.30699\/IJP.2022.541855.2760 (2022).","DOI":"10.30699\/IJP.2022.541855.2760"},{"key":"21701_CR44","doi-asserted-by":"publisher","first-page":"19393","DOI":"10.1038\/s41598-021-98457-z","volume":"11","author":"S Sharma","year":"2021","unstructured":"Sharma, S. et al. Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa. Sci Rep. 11, 19393. https:\/\/doi.org\/10.1038\/s41598-021-98457-z (2021).","journal-title":"Sci Rep."},{"key":"21701_CR45","doi-asserted-by":"publisher","unstructured":"Pradal, I. et al. Enterococcus faecium Bacteriophage vB_efah_163, a new member of the Herelleviridae family, reduces the mortality associated with an E. faecium vanR clinical isolate in a Galleria mellonella animal model, Viruses, 15.1, 179. https:\/\/doi.org\/10.3390\/v15010179 (2023).","DOI":"10.3390\/v15010179"},{"issue":"8","key":"21701_CR46","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1128\/JB.180.8.2110-2117.1998","volume":"180","author":"S Krogh","year":"1998","unstructured":"Krogh, S., J\u00f8rgensen, S. T. & Devine, K. M. Lysis genes of the Bacillus subtilis defective prophage PBSX. J. Bacteriol. 180(8), 2110\u20132117. https:\/\/doi.org\/10.1128\/JB.180.8.2110-2117.1998 (1998).","journal-title":"J. Bacteriol."},{"key":"21701_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.virol.2016.10.030","volume":"500","author":"S Fernandes","year":"2017","unstructured":"Fernandes, S. & S\u00e3o-Jos\u00e9, C. Probing the function of the two holin-like proteins of bacteriophage SPP1. Virology 500, 184\u2013189. https:\/\/doi.org\/10.1016\/j.virol.2016.10.030 (2017).","journal-title":"Virology"},{"key":"21701_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5414\/cn107216","volume":"77","author":"R F\u00fcnfst\u00fcck","year":"2012","unstructured":"F\u00fcnfst\u00fcck, R. et al. Urinary tract infection in patients with diabetes mellitus. Clin. Nephrol. 77, 40\u201348. https:\/\/doi.org\/10.5414\/cn107216 (2012).","journal-title":"Clin. Nephrol."},{"key":"21701_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jmii.2011.12.024","volume":"46","author":"MC Wang","year":"2013","unstructured":"Wang, M. C. et al. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. J. Microbiol. Immunol. Infect. 46, 24\u201329. https:\/\/doi.org\/10.1016\/j.jmii.2011.12.024 (2013).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"21701_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocontrol.2022.104922","volume":"170","author":"N Manbua","year":"2022","unstructured":"Manbua, N., Suteewong, T. & Sae-Ueng, U. Efficacy of sugar excipients on lyophilized C22 phage infectivity evaluated by atomic force microscopy. Biol. Control 170, 104922 (2022).","journal-title":"Biol. Control"},{"issue":"1","key":"21701_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/668770","volume":"34","author":"DM Sievert","year":"2013","unstructured":"Sievert, D. M. et al. Antimicrobial resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010. Infect Control Hosp. Epidemiol. 34(1), 1\u201314. https:\/\/doi.org\/10.1086\/668770 (2013).","journal-title":"Infect Control Hosp. Epidemiol."},{"key":"21701_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1469-0691.12236","volume":"20","author":"M Pinholt","year":"2014","unstructured":"Pinholt, M. et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006\u20132009: a population-based cohort study. Clin. Microbiol. Infect. 20, 145\u2013151. https:\/\/doi.org\/10.1111\/1469-0691.12236 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"21701_CR53","doi-asserted-by":"publisher","unstructured":"Del Turco Rosselli, E. et al. How do I manage a patient with enterococcal bacteraemia?, Clin Microbiol Infect. 27,364\u2013371 (2021). https:\/\/doi.org\/10.1016\/j.cmi.2020.10.029.","DOI":"10.1016\/j.cmi.2020.10.029"},{"issue":"3","key":"21701_CR54","doi-asserted-by":"publisher","first-page":"e03396","DOI":"10.1128\/mbio.03396-23","volume":"15","author":"ME Stellfox","year":"2024","unstructured":"Stellfox, M. E. et al. Bacteriophage and antibiotic combination therapy for recurrent Enterococcus faecium bacteremia. MBio 15(3), e03396-e3423. https:\/\/doi.org\/10.1128\/mbio.03396-23 (2024).","journal-title":"MBio"},{"issue":"1","key":"21701_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/bbrj.bbrj_93_17","volume":"2","author":"VS Gondil","year":"2018","unstructured":"Gondil, V. S. & Chhibber, S. Exploring potential of phage therapy for tuberculosis using model organisms. Biomed. Biomed. Biotechnol. Res. J. 2(1), 9\u201315. https:\/\/doi.org\/10.4103\/bbrj.bbrj_93_17 (2018).","journal-title":"Biomed. Biomed. Biotechnol. Res. J."},{"key":"21701_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mib.2017.09.004","volume":"39","author":"DP Pires","year":"2017","unstructured":"Pires, D. P. et al. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr. Opin. Microbiol. 39, 48\u201356. https:\/\/doi.org\/10.1016\/j.mib.2017.09.004 (2017).","journal-title":"Curr. Opin. Microbiol."},{"issue":"8","key":"21701_CR57","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AEM.00096-15","volume":"81","author":"L Khalifa","year":"2015","unstructured":"Khalifa, L. et al. Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol. 81(8), 2696\u20132705. https:\/\/doi.org\/10.1128\/AEM.00096-15 (2015).","journal-title":"Appl Environ Microbiol."},{"key":"21701_CR58","doi-asserted-by":"publisher","unstructured":"Tinoco, J.M. et a. Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms. Arch. Oral Biol.. 71, 80\u201386. https:\/\/doi.org\/10.1016\/j.archoralbio.2016.07.001 (2016).","DOI":"10.1016\/j.archoralbio.2016.07.001"},{"key":"21701_CR59","doi-asserted-by":"publisher","unstructured":"Zhang, W. et al. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin. PLoS One. 13;8, e80435 (2013). https:\/\/doi.org\/10.1371\/journal.pone.0080435.","DOI":"10.1371\/journal.pone.0080435"},{"issue":"2","key":"21701_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00705-006-0849-1","volume":"152","author":"HW Ackermann","year":"2007","unstructured":"Ackermann, H. W. 5500Phages examined in the electron microscope. Arch Virol. 152(2), 227\u2013243. https:\/\/doi.org\/10.1007\/s00705-006-0849-1 (2007).","journal-title":"Arch Virol."},{"key":"21701_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2016.02.006","volume":"492","author":"P Gong","year":"2016","unstructured":"Gong, P. et al. Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5. Virology 492, 11\u201320. https:\/\/doi.org\/10.1016\/j.virol.2016.02.006 (2016).","journal-title":"Virology"},{"key":"21701_CR62","doi-asserted-by":"publisher","unstructured":"Soro, O. et al. Complete genome sequences of four lytic bacteriophages against multidrug-resistant Enterococcus faecium. Microbiol Resour Announc. 10 Oct e0068824 (2024). https:\/\/doi.org\/10.1128\/mra.00688-24.","DOI":"10.1128\/mra.00688-24"},{"key":"21701_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fmicb.2014.00051","volume":"18","author":"MH Ly-Chatain","year":"2014","unstructured":"Ly-Chatain, M. H. The factors affecting effectiveness of treatment in phagestherapy. Front Microbiol. 18, 5\u201351. https:\/\/doi.org\/10.3389\/fmicb.2014.00051 (2014).","journal-title":"Front Microbiol."},{"key":"21701_CR64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","volume":"24","author":"DP Pires","year":"2020","unstructured":"Pires, D. P. et al. Current challenges and future opportunities of phage therapy. FEMS Microbiol Rev. 24, 684\u2013700. https:\/\/doi.org\/10.1093\/femsre\/fuaa017 (2020).","journal-title":"FEMS Microbiol Rev."},{"key":"21701_CR65","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/v16081275","volume":"16","author":"O Soro","year":"2024","unstructured":"Soro, O. et al. Characterization and Anti-Biofilm Activity of Lytic Enterococcus Phage vB_Efs8_KEN04 against Clinical Isolates of Multidrug-Resistant Enterococcus faecalis in Kenya. Viruses 16, 1275. https:\/\/doi.org\/10.3390\/v16081275 (2024).","journal-title":"Viruses"},{"key":"21701_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198599","volume":"307","author":"S Rigvava","year":"2022","unstructured":"Rigvava, S. et al. Novel lytic bacteriophage vB_GEC_EfS_9 against Enterococcus faecium. Virus Res. 307, 198599. https:\/\/doi.org\/10.1016\/j.virusres.2021.198599 (2022).","journal-title":"Virus Res."},{"key":"21701_CR67","doi-asserted-by":"publisher","first-page":"13048","DOI":"10.1038\/s41598-022-17275-z","volume":"29","author":"DM El-Atrees","year":"2022","unstructured":"El-Atrees, D. M. et al. Characterization and anti-biofilm activity of bacteriophages against urinary tract Enterococcus faecalis isolates. Sci Rep. 29, 13048. https:\/\/doi.org\/10.1038\/s41598-022-17275-z (2022).","journal-title":"Sci Rep."},{"key":"21701_CR68","doi-asserted-by":"publisher","first-page":"1210319","DOI":"10.3389\/fmicb.2023.1210319","volume":"14","author":"F Song","year":"2023","unstructured":"Song, F. et al. Characterization of an Enterococcus faecalis bacteriophage SFQ1 as a potential therapeutic agent. Front. Microbiol. 14, 1210319. https:\/\/doi.org\/10.3389\/fmicb.2023.1210319 (2023).","journal-title":"Front. Microbiol."},{"key":"21701_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.698807","volume":"1611","author":"M Song","year":"2021","unstructured":"Song, M. et al. Characterization of an Enterococcus faecalis Bacteriophage vB_EfaM_LG1 and Its Synergistic Effect With Antibiotic. Front Cell Infect Microbiol. 1611, 698807. https:\/\/doi.org\/10.3389\/fcimb.2021.698807 (2021).","journal-title":"Front Cell Infect Microbiol."},{"key":"21701_CR70","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","volume":"8","author":"BK Chan","year":"2013","unstructured":"Chan, B. K., Abedon, S. T. & Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 8, 769\u2013783. https:\/\/doi.org\/10.2217\/fmb.13.47 (2013).","journal-title":"Future Microbiol."},{"key":"21701_CR71","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11262-018-1608-6","volume":"54","author":"R Wang","year":"2018","unstructured":"Wang, R. et al. Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis. Virus Genes 54, 804\u2013881. https:\/\/doi.org\/10.1007\/s11262-018-1608-6 (2018).","journal-title":"Virus Genes"},{"key":"21701_CR72","doi-asserted-by":"publisher","unstructured":"Melo, L. D. R. et al. Efficacy and safety assessment of two enterococci phages in an in vitro biofilm wound model. Sci. Rep. 30, 6643. https:\/\/doi.org\/10.1038\/s41598-019-43115-8  (2019) (Erratum in: Sci Rep. 20, 11008 (2021). https:\/\/doi.org\/10.1038\/s41598-021-90464-4).","DOI":"10.1038\/s41598-019-43115-8"},{"key":"21701_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301292","volume":"14","author":"S Abed","year":"2024","unstructured":"Abed, S. et al. Insights into the novel Enterococcus faecalis phage: A comprehensive genome analysis. PLoS ONE 14, e0301292. https:\/\/doi.org\/10.1371\/journal.pone.0301292 (2024).","journal-title":"PLoS ONE"},{"key":"21701_CR74","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/v10040163","volume":"30","author":"E Casey","year":"2018","unstructured":"Casey, E., van Sinderen, D. & Mahony, J. In Vitro Characteristics of Phages to Guide \u201cReal Life\u201d Phage Therapy Suitability. Viruses 30, 163. https:\/\/doi.org\/10.3390\/v10040163 (2018).","journal-title":"Viruses"},{"key":"21701_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-9-24","volume":"9","author":"Y Yin","year":"2008","unstructured":"Yin, Y. & Fischer, D. Identification and investigation of ORFans in the viral world. BMC Genom. 9, 1\u201310. https:\/\/doi.org\/10.1186\/1471-2164-9-24 (2008).","journal-title":"BMC Genom."},{"key":"21701_CR76","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/07388551.2014.993587","volume":"36","author":"L Rodr\u00edguez-Rubio","year":"2016","unstructured":"Rodr\u00edguez-Rubio, L. et al. Phage lytic proteins: biotechnological applications beyond clinical antimicrobials. Crit Rev Biotechnol. 36, 542\u2013552. https:\/\/doi.org\/10.3109\/07388551.2014.993587 (2016).","journal-title":"Crit Rev Biotechnol."},{"key":"21701_CR77","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.3390\/ijms222212460","volume":"18","author":"M W\u00f3jcicki","year":"2021","unstructured":"W\u00f3jcicki, M. et al. Characterization and Genome Study of Novel Lytic Bacteriophages against Prevailing Saprophytic Bacterial Microflora of Minimally Processed Plant-Based Food Products. Int J Mol Sci. 18, 12460. https:\/\/doi.org\/10.3390\/ijms222212460 (2021).","journal-title":"Int J Mol Sci."},{"key":"21701_CR78","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3389\/fmicb.2019.02877","volume":"10","author":"D Lee","year":"2019","unstructured":"Lee, D. et al. The novel Enterococcus phage vB_EfaS_HEf13 has broad lytic activity against clinical isolates of Enterococcus faecalis. Frontiers in Microbiol 10, 2877 (2019).","journal-title":"Frontiers in Microbiol"},{"key":"21701_CR79","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/antibiotics9050268","volume":"9","author":"C Ferriol-Gonzalez","year":"2020","unstructured":"Ferriol-Gonzalez, C. & Domingo-Calap, P. Phages for Biofilm Removal. Antibiotics. 9, 268. https:\/\/doi.org\/10.3390\/antibiotics9050268 (2020).","journal-title":"Antibiotics."},{"key":"21701_CR80","doi-asserted-by":"publisher","first-page":"691","DOI":"10.18502\/ijm.v13i5.7436","volume":"13","author":"F Goodarzi","year":"2021","unstructured":"Goodarzi, F. et al. Biological characteristics and anti-biofilm activity of a lytic phage against vancomycin-resistant Enterococcus faecium. Iran J. Microbiol. 13, 691\u2013702. https:\/\/doi.org\/10.18502\/ijm.v13i5.7436 (2021).","journal-title":"Iran J. Microbiol."},{"key":"21701_CR81","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11262-023-02016-9","volume":"59","author":"Q Qu","year":"2023","unstructured":"Qu, Q. et al. Isolation and characterization of a novel lytic bacteriophage vB_Efm_LG62 infecting Enterococcus faecium. Virus Genes 59, 763\u2013774. https:\/\/doi.org\/10.1007\/s11262-023-02016-9 (2023).","journal-title":"Virus Genes"},{"key":"21701_CR82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","volume":"30","author":"Z Chegini","year":"2020","unstructured":"Chegini, Z. et al. A Shariati, Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob. 30, 45. https:\/\/doi.org\/10.1186\/s12941-020-00389-5 (2020).","journal-title":"Ann Clin Microbiol Antimicrob."},{"key":"21701_CR83","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.aax3760","volume":"366","author":"CK Stein-Thoeringer","year":"2019","unstructured":"Stein-Thoeringer, C. K. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 366, 1143\u20131149. https:\/\/doi.org\/10.1126\/science.aax3760 (2019).","journal-title":"Science"},{"key":"21701_CR84","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1078\/072320203322345985","volume":"26","author":"MC Rea","year":"2003","unstructured":"Rea, M. C. & Cogan, T. M. Catabolite repression in Enterococcus faecalis. Syst. Appl. Microbiol. 26, 159\u2013164. https:\/\/doi.org\/10.1078\/072320203322345985 (2003).","journal-title":"Syst. Appl. Microbiol."},{"key":"21701_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2021.757227","volume":"12","author":"S Reissier","year":"2021","unstructured":"Reissier, S. The Regulatory RNA ern0160 Confers a Potential Selective Advantage to Enterococcus faecium for Intestinal Colonization. Front. Microbiol. 12, 1\u20139. https:\/\/doi.org\/10.3389\/fmicb.2021.757227 (2021).","journal-title":"Front. Microbiol."},{"key":"21701_CR86","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11515-012-1183-5","volume":"7","author":"ML Quiloan","year":"2012","unstructured":"Quiloan, M. L., Vu, J. & Carvalho, J. Enterococcus faecalis can be distinguished from Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation characteristics on mannitol salt agar. Front. Biol. 7, 167\u2013177. https:\/\/doi.org\/10.1007\/s11515-012-1183-5 (2012).","journal-title":"Front. Biol."},{"key":"21701_CR87","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1128\/jb.86.6.1275-1282.1963","volume":"86","author":"RH Deibel","year":"1963","unstructured":"Deibel, R. H., Lake, D. E. & Niven, C. F. Jr. Physiology of the enterococci as related to their taxonomy. J. Bacteriol. 86, 1275\u20131282 (1963).","journal-title":"J. Bacteriol."},{"key":"21701_CR88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.joen.2005.10.049","volume":"32","author":"CH Stuart","year":"2006","unstructured":"Stuart, C. H., Schwartz, S. A., Beeson, T. J. & Owatz, C. B. Enterococcus faecalis: Its role in root canal treatment failure and current concepts in retreatment. J. Endod. 32, 93\u201398. https:\/\/doi.org\/10.1016\/j.joen.2005.10.049 (2006).","journal-title":"J. Endod."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21701-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21701-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:03:18Z","timestamp":1762138998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21701-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21701"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21701-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37819"}}